Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Diabetes 26:29-33, 2008
DOI: 10.2337/diaclin.26.1.29
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahady, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shahady, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Bridges to Excellence

The Florida Diabetes Master Clinician Program: Facilitating Increased Quality and Significant Cost Savings for Diabetic Patients

Edward Shahady, MD, ABCL, ABFM, FAAFP

The first 300 words of the full text of this article appear below.


    Introduction
 
Up to 10% of Americans > 20 years of age have type 2 diabetes, and > 20% have the metabolic syndrome.1,2 The prevalence of both has increased by 33% during the past decade as a result of an increasingly sedentary lifestyle, the epidemic of obesity, the growth of ethnic groups at risk for the disease, and the aging of the population. The prevalence of the metabolic syndrome increases dramatically with age, and 45% of people > 60 years of age have the syndrome. Type 2 diabetes will develop in many of these individuals.1,2

In the United States, diabetes is the sixth leading cause of death; the leading cause of renal failure (end-stage renal disease), nontraumatic limb amputations, and blindness; and the leading contributor to cardiovascular disease (CVD). CVD accounts for ~ 70% of deaths in adults with diabetes. The complications associated with diabetes lead to excessive suffering, increased use of health care resources, and excessive costs.3-6

Despite our increased knowledge and understanding of the pathophysiology and management of diabetes, patient outcomes have not shown a parallel improvement. A large gap exists between our knowledge and our performance.7,8 Based on excellent evidence, the American Diabetes Association (ADA) has set the following goals: hemoglobin A1c (A1C) ≤ 7%, LDL cholesterol ≤ 100 mg/dl, and blood pressure ≤ 130/80 mmHg. Nationally, only 48% of patients are able to reach the A1C goal, and only 33% are at the LDL and blood pressure goals. Only 7% are able to reach the goal for all three at the same time.9 The 58 Florida practices that participate in the Diabetes Master Clinician Program (DMCP) of the Florida Academy of Family Physicians Foundation (FAFPF) have been able to help patients attain better control of their diabetes than the national averages. The 8,657 patients (27,920 visits) in the 58 practices average 54% . . . [Full Text of this Article]


    Summary
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.